"
Team:ULB-Brussels/mat
From 2011.igem.org
| Line 571: | Line 571: | ||
| + | |||
| Line 585: | Line 586: | ||
<li><strong>PKD46-REV: </strong></li> | <li><strong>PKD46-REV: </strong></li> | ||
</ul> | </ul> | ||
| - | <p | + | <p>5’-<span class="vert">c</span><span class="vert">gtgagttttcgttccactgagcgtcagaccccgtagaaa</span>gagttttcgttccactgagc-3’</p> |
<ul> | <ul> | ||
<li><strong>PFL-FOR</strong>: </li> | <li><strong>PFL-FOR</strong>: </li> | ||
</ul> | </ul> | ||
| - | <p>5’- | + | <p>5’-gcctttttacggttcctggc-3’</p> |
<ul> | <ul> | ||
<li><strong>PFL-REV: </strong></li> | <li><strong>PFL-REV: </strong></li> | ||
</ul> | </ul> | ||
| - | <p | + | <p>5’-tttctacgggggtctgacgc-3’</p> |
<ul> | <ul> | ||
<li><strong>PCP-FOR:</strong></li> | <li><strong>PCP-FOR:</strong></li> | ||
| Line 608: | Line 609: | ||
<li><strong>FLP/CI-FOR: </strong></li> | <li><strong>FLP/CI-FOR: </strong></li> | ||
</ul> | </ul> | ||
| - | <p>5’- | + | <p>5’-acatggcgagttttgacgag-3’<strong></strong></p> |
<ul> | <ul> | ||
<li><strong>FLP/CI-REV: </strong></li> | <li><strong>FLP/CI-REV: </strong></li> | ||
| Line 660: | Line 661: | ||
<p> 5’-<span class="vert">gaagttcctatactttttagagaataggaacttc</span>gttgatcgggcacgtaagagg-3’ </p> | <p> 5’-<span class="vert">gaagttcctatactttttagagaataggaacttc</span>gttgatcgggcacgtaagagg-3’ </p> | ||
<ul> | <ul> | ||
| - | <li><strong>FRT'-CM-FRT'-REV </strong>: | + | <li><strong>FRT'-CM-FRT'-REV </strong>:</li> |
| - | + | ||
| - | + | ||
</ul> | </ul> | ||
| + | <p>5’-<span class="vert">gaagttcctattctctaaaaagtataggaacttc</span>ttattacgccccgccctgcc-3’ </p> | ||
<p><strong>In green is the frt’ sequence which is not homologous with the chloramphenicol gene.</strong></p> | <p><strong>In green is the frt’ sequence which is not homologous with the chloramphenicol gene.</strong></p> | ||
<ul> | <ul> | ||
| Line 678: | Line 678: | ||
<li><strong>FRT’-CM-FRT’-SEQ-FOR: </strong></li> | <li><strong>FRT’-CM-FRT’-SEQ-FOR: </strong></li> | ||
</ul> | </ul> | ||
| - | <p>5’- | + | <p>5’-gaggaaacagctatga-3’</p> |
<ul> | <ul> | ||
<li><strong>FRT’-CM-FRT’-SEQ-REV:</strong></li> | <li><strong>FRT’-CM-FRT’-SEQ-REV:</strong></li> | ||
Revision as of 13:27, 21 September 2011
Primers
The following primers were produced by Sigma-Aldrich (option desalt)
Yeast cloning:
- PKD46-FOR:
5’- gagcaaaaggccagcaaaaggccaggaaccgtaaaaaggctgccacctgcatcgatttat-3’
- PKD46-REV:
5’-cgtgagttttcgttccactgagcgtcagaccccgtagaaagagttttcgttccactgagc-3’
- PFL-FOR:
5’-gcctttttacggttcctggc-3’
- PFL-REV:
5’-tttctacgggggtctgacgc-3’
- PCP-FOR:
5’-tggctcttgtatctatcagtgaagcatcaagactaacaaatcagccaaacgtctcttcag-3’
- PCP-REV:
5’-ggggctgtatgcacaaagcatcttctgttgagttaagaacttatatgcgtctatttatgtagg-3’
In green is the 40 homologous nucleotides need for the yeast cloning.
Yeast cloning verification:
- FLP/CI-FOR:
5’-acatggcgagttttgacgag-3’
- FLP/CI-REV:
5’-accacactagagaacatactg-3’
pINDEL sequencing:
- pID-seq1:
5’-aggatcttcacctagatcctt-3’
- pID-seq2:
5’-gatgggctagtcaatgataatta-3’
- pID-seq3:
5’-ccgttacgtaggtaggaatc-3’
- pID-seq4:
5’-agatggggatggggcagtc-3’
- pID-seq5:
5’-gatttcggatcaacgttcttaat-3’
- pID-seq6:
5’-caatcactttcgtctactcc-3’
- pID-seq7:
5’-ccagatatttcgccgcgac-3’
- pID-seq8:
5’-cggggccagcaaaaaatcca-3’
- pID-seq9:
5’-ccctgatttttcaccacccc-3’
- pID-seq10:
5’-cttccgaaaatgcaacgcga-3’
Biobrick frt’-cm-frt’
- FRT’-CM-FRT’-FOR:
5’-gaagttcctatactttttagagaataggaacttcgttgatcgggcacgtaagagg-3’
- FRT'-CM-FRT'-REV :
5’-gaagttcctattctctaaaaagtataggaacttcttattacgccccgccctgcc-3’
In green is the frt’ sequence which is not homologous with the chloramphenicol gene.
- TOPO-FRT'-CM-FRT'-FOR:
5'-tccggcaaaaaagggcaaggtgtcaccaccctgcccttttcgccagtgtgctggatttc-3'
- TOPO-FRT'-CM-FRT'-REV:
5’-tgcagcggccgctactagtactctagaagcggccgcgaatgatggatatctgcagatttc-3’
In red is the iGEM restriction sites (prefix and suffix) and in green is the mutation made to suppress the EcoRI restriction site (in the Topo® XL PCR plasmid).
Biobrick FRT'-CM-FRT' sequencing (primer M13 as described in Topo® XL PCR Kit)
- FRT’-CM-FRT’-SEQ-FOR:
5’-gaggaaacagctatga-3’
- FRT’-CM-FRT’-SEQ-REV:
5’-gaccggcagcaaatg-3’
